Back to top
more

T. Rowe Price Health Sciences Fund Inc.: (MF: PRHSX)

(NASDAQ Mutual Funds) As of Jan 23, 2026 05:45 PM ET

$85.31 USD

-0.94 (-1.09%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

2-Buy of 5   2      

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Dec 31, 2025

Total Return %* Percentile Rank Objective
YTD 17.71 39
3 months 15.44 29
6 months 21.21 50
1 Year 17.71 39
3 Year 7.30 56
5 Year 4.20 60
10 Year 9.13 27

* Annual for three years and beyond.

Zacks Premium Research for PRHSX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Buy 2
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 48.67
% Yield 0.11
% SEC Yield NA
Net Assets (Mil $) 12/31/2025 6,557.00
% Turnover 12/31/2025 45.20

Risk

3 Year 5 Year 10 Year
Beta 0.67 0.69 0.82
Alpha -7.68 -5.64 -2.55
R Squared 0.30 0.45 0.54
Std. Dev. 14.52 15.42 16.89
Sharpe 0.24 0.14 3.00

Sector / Country Weightings

As of 12/31/2025 % of Portfolio
Health 61.31
Other 9.83
Finance 9.82
Services 8.22
Technology 4.64
Industrial Cyclical 3.08
Retail Trade 3.07
Consumer Durables 0.03

Portfolio Holdings

Top Equity Holdings
(As of 9/30/2025)
% of Portfolio Value (Mil$)
ELI LILLY & CO 8.73 960.25
INTUITIVE SURGICAL INC 4.76 523.68
STRYKER CORP 4.59 504.71
ARGENX SE ADR 4.58 503.78
TOTAL*MISCELLANEOUS 4.33 477.07
UNITEDHEALTH GROUP INC 4.10 451.29
THERMO FISHER SCIENTIFIC 3.78 415.83
ABBVIE INC 3.37 370.76
ALNYLAM PHARMACEUTICALS I 3.27 359.78

Stock Holding % of Net Assets

As Of 9/30/2025
Total Issues 172
Avg. P/E 29.24
Avg. P/Book 5.60
Avg. EPS Growth 13.41
Avg. Market Value (Mil $) 165,302

Composition

% of Portfolio
Stocks 91.13
Foreign Stocks 13.72
Cash 0.40
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.18
Convertible 4.43
Other 3.85
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth NA
Large Value NA
Small Growth NA
Small Value NA
Foreign Stock NA
Emerging Market NA
Precious Metal NA
Intermediate Bond NA
Foreign Bond NA
High Yield Bond NA